Purpose—Symptomatic intracranial hemorrhage (sICH) is the most feared complication of
intravenous thrombolytic therapy in acute ischemic stroke. Treatment of sICH is based on …

Background: There are many prognostic scales that aim to predict functional outcome
following acute stroke. Despite considerable research interest, these scales have had …

Background There is limited data on predictors of symptomatic intracranial haemorrhage
(sICH) in patients who underwent mechanical thrombectomy. In this study, we aim to …

Background The treatment of stroke has been undergoing rapid changes. As treatment
options progress, prediction of those under risk for complications becomes more important …

Background We aimed to develop a tool, the hemorrhagic transformation (HT) index (HTI), to
predict any HT within 14 days after middle cerebral artery (MCA) stroke onset regardless of …

Background and purpose ASTRAL, SEDAN and DRAGON scores are three well‐validated
scores for stroke outcome prediction. Whether these scores predict stroke outcome more …

Background: Clinical and biological risk factors for hemorrhagic transformation (HT) after
intravenous thrombolysis (IT) have been well-established in several registries. The added …

Background: Intravenous thrombolysis (IVT) is a standard treatment for both anterior
circulation ischemic stroke (ACIS) and posterior circulation ischemic stroke (PCIS). PCIS is a …

Artificial intelligence (AI) is making a profound impact in healthcare, with the number of AI
applications in medicine increasing substantially over the past five years. In acute stroke, it is …

Cardiocerebrovascular diseases (CVDs) are the leading cause of death worldwide,
consuming huge healthcare budget. For CVD patients, the prompt assessment and …